Prospects for use of peptides and their derivatives, structurally corresponding to the G protein-coupled receptors, in medicine

Biomedit︠s︡inskai︠a︡ khimii︠a︡
A O Shpakov, E A Shpakova

Abstract

The regulation of signaling pathways involved in the control of many physiological functions is carried out via the heterotrimeric G protein-coupled receptors (GPCR). The search of effective and selective regulators of GPCR and intracellular signaling cascades coupled with them is one of the important problems of modern fundamental and clinical medicine. Recently data suggest that synthetic peptides and their derivatives, structurally corresponding to the intracellular and transmembrane regions of GPCR, can interact with high efficiency and selectivity with homologous receptors and influence, thus, the functional activity of intracellular signaling cascades and fundamental cellular processes controlled by them. GPCR-peptides are active in both in vitro and in vivo. They regulate hematopoiesis, angiogenesis and cell proliferation, inhibit tumor growth and metastasis, and prevent the inflammatory diseases and septic shock. These data show greatest prospects in the development of the new generations of drugs based on GPCR-derived peptides, capable of regulating the important functions of the organism.

References

Sep 8, 1994·Biochimica Et Biophysica Acta·B König, M Grätzel
Jan 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Lidija CovicAthan Kuliopulos
Jan 23, 2003·The Journal of Pharmacology and Experimental Therapeutics·Claudia K DerianPatricia Andrade-Gordon
Oct 17, 2006·Biophysical Journal·Jessica PlatiDale F Mierke
Oct 30, 2007·Nature Immunology·Nicole C KaneiderAthan Kuliopulos
Oct 20, 2009·Biochemical and Biophysical Research Communications·Won-Kyu LeeYeon Gyu Yu
Nov 21, 2009·Annals of the New York Academy of Sciences·Jacquelyn MillerStephen W Hunt
Nov 6, 2010·Methods in Molecular Biology·Sarah L TresselAthan Kuliopulos
Dec 9, 2010·Proceedings of the National Academy of Sciences of the United States of America·Boris TchernychevKenneth E Carlson
Feb 1, 2011·Pharmacology & Therapeutics·Mark N AdamsJohn D Hooper
May 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Leila M SevignyAthan Kuliopulos
Jun 28, 2011·The American Journal of Pathology·Jaroslaw CisowskiLidija Covic
Sep 13, 2011·Journal of the American Chemical Society·Jay M JanzThomas P Sakmar
Sep 24, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Leila M SevignyAthan Kuliopulos
Jan 11, 2012·Current Pharmaceutical Design·Iason KyriazisChristodoulos Flordellis
Jun 1, 2012·International Journal of Peptides·Brian HallKeith K Parker
Jun 19, 2012·Circulation·Ahmed Abdel-Latif, Susan S Smyth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Zhurnal evoliutsionnoĭ biokhimii i fiziologii
A O Shpakov, K V Derkach
Mini Reviews in Medicinal Chemistry
J González-Maeso, S C Sealfon
Progress in Molecular Biology and Translational Science
Benita SjögrenR R Neubig
© 2021 Meta ULC. All rights reserved